Since the outbreak of COVID-19, many U.S. agencies have stated that current investigations will proceed, and the government will commence new inquiries. Indeed, this is not a time for companies to let down their guard. Because most companies are operating remotely, they should be prepared, as the government is, to leverage technology as a substitute for typical in-person investigation-related activities. While technology makes remote investigations manageable, there are key flexibility and best-practice considerations to assist companies in preserving investigative integrity, confidentiality, and independence throughout the crisis.

Investigative Agency Responses to COVID-19

The COVID-19 pandemic has had a unique impact on U.S. agencies. The Federal Bureau of Investigation (FBI), while operating primarily within a remote platform, is functioning more or less normally. Others are de-prioritizing investigations unrelated to the current health crisis, as employees and resources are redirected at an unprecedented level. Further, agencies led by more explicitly political actors, such as state attorney general offices, are likely to shift their near term focus to matters related to COVID-19. The same is true for agencies that include healthcare issues as part of their regular investigative portfolio.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]